Product
LB54640
2 clinical trials
4 indications
Indication
Hypothalamic ObesityIndication
Proopiomelanocortin Deficiency ObesityIndication
PCSK1 Deficiency ObesityIndication
Leptin receptor deficiencyClinical trial
A Randomized, Placebo-controlled, Double-Blind Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity, With an Open-Label ExtensionStatus: Not yet recruiting, Estimated PCD: 2026-01-31
Clinical trial
A Phase 2, Single-arm, Open-label Study to Assess Efficacy and Safety of LB54640 in Patients With Obesity Due to POMC, PCSK1, or LEPR Deficiency.Status: Not yet recruiting, Estimated PCD: 2024-12-01